Characteristics of Mid-Frequency Sensorineural Hearing Loss Progression.


Journal

Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology
ISSN: 1537-4505
Titre abrégé: Otol Neurotol
Pays: United States
ID NLM: 100961504

Informations de publication

Date de publication:
06 2019
Historique:
entrez: 15 5 2019
pubmed: 15 5 2019
medline: 21 4 2020
Statut: ppublish

Résumé

To characterize the progression of mid-frequency sensorineural hearing loss (MFSNHL) over time. A retrospective chart review spanning 2012 to 2017 was performed at a tertiary care audiology and neurotology center. Our cohort included 37 patients met the criteria for MFSNHL also known as "cookie bite hearing loss." It was defined as having a 1, 2, and 4 kHz average pure tone audiometry greater than 10 dB in intensity compared with the average threshold at 500 Hz and 8 kHz. Average age at initial presentation was 11.8 years (range, 8 mo to 70 yr). Across all individuals, the average mid-frequency threshold was 47 dB, compared with 27 dB at 500 Hz and 8 kHz. Twenty-three patients (62%) had multiple audiograms with 4-year median follow up time. Average values across all frequencies (0.5, 1, 2, 4, 8 kHz) in the initial audiogram was 37 dB, compared with an average of 39 dB demonstrated on final audiogram. Of those with serial audiograms, only five patients demonstrated threshold changes of 10 dB or more. Of these five patients, only one was found to have clinical worsening of MFSNHL. MFSNHL is an uncommon audiometric finding with unspecified long-term outcomes. We demonstrated that most patients (96%) with MFSNHL do not experience clinical worsening of their hearing threshold over almost 4 years of follow up. Future prospective studies aimed at collecting longer-term data are warranted to further elucidate the long-term trajectory of MFSNHL patients.

Identifiants

pubmed: 31083079
doi: 10.1097/MAO.0000000000002232
pii: 00129492-201906000-00008
pmc: PMC8040769
mid: NIHMS1687237
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e497-e502

Subventions

Organisme : NCATS NIH HHS
ID : TL1 TR001415
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001414
Pays : United States

Références

Am J Otol. 1998 Nov;19(6):718-23
pubmed: 9831143
Hum Mutat. 1997;9(4):300-15
pubmed: 9101290
Am J Audiol. 1999 Dec;8(2):101-5
pubmed: 10646193
Nat Genet. 1998 May;19(1):60-2
pubmed: 9590290
J Assoc Res Otolaryngol. 2007 Mar;8(1):1-7
pubmed: 17136632
Hum Genet. 2003 Jan;112(1):24-8
pubmed: 12483295
Clin Otolaryngol Allied Sci. 2000 Feb;25(1):45-54
pubmed: 10764236
Otolaryngol Head Neck Surg. 2003 Jan;128(1):92-8
pubmed: 12574765
Arch Otolaryngol Head Neck Surg. 2002 Aug;128(8):913-7
pubmed: 12162770
Clin Genet. 2007 Aug;72(2):130-7
pubmed: 17661817
Ear Hear. 1999 Dec;20(6):506-14
pubmed: 10613388
Acta Otolaryngol. 1989 May-Jun;107(5-6):474-8
pubmed: 2756840
J Med Genet. 2001 May;38(5):E13
pubmed: 11333869
Ear Hear. 2016 Jan-Feb;37(1):103-11
pubmed: 26331839
Audiology. 1997 Jul-Aug;36(4):228-36
pubmed: 9253481
PLoS One. 2018 Mar 12;13(3):e0193359
pubmed: 29529044
Environ Health. 2015 Sep 24;14:77
pubmed: 26400775
Laryngoscope. 1996 Aug;106(8):992-7
pubmed: 8699915
Br Med Bull. 2002;63:73-94
pubmed: 12324385
Audiol Neurootol. 2009;14(3):153-62
pubmed: 19005249
Otolaryngol Head Neck Surg. 1987 Jan;96(1):30-3
pubmed: 3118293
Braz J Otorhinolaryngol. 2014 Jan-Feb;80(1):35-40
pubmed: 24626890
J Laryngol Otol. 2005 Jul;119(7):529-33
pubmed: 16175977
Otolaryngol Head Neck Surg. 1995 Jul;113(1):23-31
pubmed: 7603717
Front Med. 2016 Jun;10(2):137-42
pubmed: 27142990
Orphanet J Rare Dis. 2017 Sep 25;12(1):157
pubmed: 28946916

Auteurs

Jack Birkenbeuel (J)

Department of Otolaryngology-Head and Neck Surgery.

Mehdi Abouzari (M)

Department of Otolaryngology-Head and Neck Surgery.

Khodayar Goshtasbi (K)

Department of Otolaryngology-Head and Neck Surgery.

Omid Moshtaghi (O)

Department of Otolaryngology-Head and Neck Surgery.

Ronald Sahyouni (R)

Department of Otolaryngology-Head and Neck Surgery.
Department of Biomedical Engineering, University of California, Irvine, California.

Afsheen Moshtaghi (A)

Department of Otolaryngology-Head and Neck Surgery.

Dillon Cheung (D)

Department of Otolaryngology-Head and Neck Surgery.

Donna Gelnett (D)

Department of Otolaryngology-Head and Neck Surgery.

Harrison W Lin (HW)

Department of Otolaryngology-Head and Neck Surgery.

Hamid R Djalilian (HR)

Department of Otolaryngology-Head and Neck Surgery.
Department of Biomedical Engineering, University of California, Irvine, California.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH